Epinephrine is the only medication that can stop anaphylaxis and it is critical that everyone with a food allergy has access to epinephrine to treat life threatening reactions…. read more.
Starting antiretroviral treatment (ART) early in the course of HIV infection when the immune system is stronger results in better long-term health outcomes compared with delaying ART, according… read more.
Many children live in homes with unused prescription drugs and expired medications, a new national poll suggests. Nearly half of parents say they have leftover prescription medication at… read more.
Newly discovered biological changes in mothers who suffer postpartum depression may help explain the condition, yield long-sought treatments and let doctors identify those at risk even before their… read more.
Children with food allergies, along with their parents, often experience heightened anxiety over risks of casual contact with food allergens. They also wonder whether they should avoid social… read more.
A new study published today in Arthritis & Rheumatology led by researchers at Baylor College of Medicine reveals that walking for exercise can reduce new frequent knee pain among people… read more.
Lessons learned from the public health responses to the HIV and COVID-19 pandemics should help guide the response to the current outbreak of monkeypox, National Institutes of Health… read more.
Treatment with dupilumab appears to improve survival rates for patients with moderate to severe COVID-19. Researchers reported these findings on August 16, 2022 in Open Forum of Infectious… read more.
People who supplement rescue inhalers with a second asthma medication sometimes get little relief at first, but there’s good news: Those who keep trying different options often find… read more.
UBC researchers demonstrated in 2019 that pre-schoolers can safely overcome peanut allergies with a treatment called oral immunotherapy. Now they have evidence that the earlier pre-schoolers start this… read more.
Amgen announced results from a pooled post-hoc analysis of the pivotal NAVIGATOR Phase III and PATHWAY Phase IIb trials showed Tezspire (tezepelumab-ekko) demonstrated reductions in the annualized asthma… read more.
A new protein-based antiviral nasal spray developed by researchers at Northwestern University, University of Washington and Washington University at St. Louis is being advanced toward Phase I human… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
